Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis (Q58041112)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Greg C Brown

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Alan Coulthard

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

D Vanags

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

B Williams

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

B Johnson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D Feeney

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S Shakib

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

P Mullins

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

C Kneebone

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

S A Broadley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

27 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

329-336

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

A protective effect of early pregnancy factor on experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Early pregnancy factor suppresses experimental autoimmune encephalomyelitis induced in Lewis rats with myelin basic protein and in SJL/J mice with myelin proteolipid protein peptide 139-151

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Early pregnancy factor treatment suppresses the inflammatory response and adhesion molecule expression in the spinal cord of SJL/J mice with experimental autoimmune encephalomyelitis and the delayed-type hypersensitivity reaction to trinitrochlorobe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Recombinant EPF/chaperonin 10 promotes the survival of O4-positive pro-oligodendrocytes prepared from neonatal rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508099141

21 January 2018

Identifiers

DOI

10.1177/1352458508099141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039022%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference